Evidence map›Paper›PMID 40264966›Full record

ArticleEuropean journal of obstetrics & gynecology and reproductive biology: X2025

The landscape of ovarian cancer surgery in Italy: Data from PNE.

Laura Grazia Zompì, Cerbone Marco, Pietro Quarto, Christopher Clark, Tommaso Difonzo, Salvatore Lopez, Vera Loizzi, Cormio Gennaro

Abstract read
In one paragraph

Article in European journal of obstetrics & gynecology and reproductive biology: X, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Laura Grazia ZompìInterdisciplinar Department of Medicine (DIM), University of Bari, "Aldo Moro", 70124 Bari, Italy.
Cerbone MarcoInterdisciplinar Department of Medicine (DIM), University of Bari, "Aldo Moro", 70124 Bari, Italy.
Pietro QuartoInterdisciplinar Department of Medicine (DIM), University of Bari, "Aldo Moro", 70124 Bari, Italy.
Christopher ClarkInterdisciplinar Department of Medicine (DIM), University of Bari, "Aldo Moro", 70124 Bari, Italy.
Tommaso DifonzoInterdisciplinar Department of Medicine (DIM), University of Bari, "Aldo Moro", 70124 Bari, Italy.
Salvatore LopezGynecologic Oncology Unit, Istituto Tumori Giovanni Paolo II - IRCCS, University of Bari, 70124 Bari, Italy.
Vera LoizziInterdisciplinar Department of Medicine (DIM), University of Bari, "Aldo Moro", 70124 Bari, Italy.
Cormio GennaroInterdisciplinar Department of Medicine (DIM), University of Bari, "Aldo Moro", 70124 Bari, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Ovarian cancer (OC) in Italy is tenth in incidence among tumors in females, and it is the cause of 30 % of deaths due to gynecological tumors. The objective of this study is to evaluate the volume of patients undergoing surgical treatment for OC in Italian hospital facilities. Methods: An analysis of hospitalization volumes due to OC in Italian medical facilities in 2022 based on the Piano Nazionale Esiti was performed. Centers were divided into 3 categories, according to the annual number of hospitalizations due to OC (above 30, between 20 and 29, below 20); the percentage of patients treated in each category of hospitals was calculated. Additionally, an evaluation of the active mobility (meaning the number of patients living outside the region but receiving treatment in the region taken into examination) and passive mobility (meaning the number of patients living inside the examined region but choosing to receive treatment in centers located outside of the region itself) was carried out for each region. Results: The study showed that, in 11 Italian regions, most of OC cases are treated in medical centers with patient volumes of less than 20 cases per year. Only in 6 regions, OC cases are mostly treated in larger centers; in these same regions, the highest percentages of active mobility are recorded. Finally, in 6 Italian regions, passive mobility exceeds 50 % of regional cases. Conclusions: Nowadays, the landscape of OC treatment in Italy is extremely heterogeneous. In most regions, patients receive treatment in low volume centers; concurrently, huge volumes of patients hailing from the entire national territory are treated in a limited number of centers.

Identifiers

PMID40264966
PMCPMC12013392

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.